Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
Background An important feature of severe acute respiratory syndrome coronavirus 2
pathogenesis is COVID-19-associated coagulopathy, characterised by increased thrombotic and …
pathogenesis is COVID-19-associated coagulopathy, characterised by increased thrombotic and …
[HTML][HTML] Human keratinocytes express functional CD14 and toll-like receptor 4
PI Song, N Neparidze, CA Armstrong, JC Ansel… - Journal of Investigative …, 2002 - Elsevier
CD14 and the toll-like receptor 4 have been known to play an important role in
lipopolysaccharide-induced cellular responses in bacterial infections. Although CD14 and toll-like …
lipopolysaccharide-induced cellular responses in bacterial infections. Although CD14 and toll-like …
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
Natural killer T (iNKT) cells can help mediate immune surveillance against tumors in mice.
Prior studies targeting human iNKT cells were limited to therapy of advanced cancer and led …
Prior studies targeting human iNKT cells were limited to therapy of advanced cancer and led …
[HTML][HTML] Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy
…, M Shrestha, K Pendleton, AK Nooka, N Neparidze… - JCI insight, 2019 - ncbi.nlm.nih.gov
Preneoplastic lesions carry many of the antigenic targets found in cancer cells but often
exhibit prolonged dormancy. Understanding how the host response to premalignancy is …
exhibit prolonged dormancy. Understanding how the host response to premalignancy is …
[PDF][PDF] Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments
N Neparidze, J Lacy - Clin Adv Hematol Oncol, 2014 - hematologyandoncology.net
Epstein-Barr virus (EBV) is associated with a wide variety of B-cell–derived lymphoid neoplasms,
including Burkitt lymphoma, lymphomas arising in immunocompromised patients (post-…
including Burkitt lymphoma, lymphomas arising in immunocompromised patients (post-…
Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States
…, JP Bewersdorf, SF Huntington, N Neparidze… - Blood …, 2020 - ashpublications.org
The hypomethylating agents (HMAs) azacitidine and decitabine have been the de facto
standard of care for patients with acute myeloid leukemia (AML) who are unfit for intensive …
standard of care for patients with acute myeloid leukemia (AML) who are unfit for intensive …
Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents
…, X Ma, CP Gross, AJ Davidoff, N Neparidze - Blood …, 2020 - ashpublications.org
Chromosome 1 abnormalities (C1As) are common genetic aberrations among patients with
multiple myeloma (MM). We aimed to evaluate the significance of C1As among a …
multiple myeloma (MM). We aimed to evaluate the significance of C1As among a …
[HTML][HTML] Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer
…, M Samur, S McCachren, SN Gettinger, N Neparidze… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND PD-1 and PD-L1 have been studied interchangeably in the clinic as
checkpoints to reinvigorate T cells in diverse tumor types. Data for biologic effects of checkpoint …
checkpoints to reinvigorate T cells in diverse tumor types. Data for biologic effects of checkpoint …
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
Comprehensive preclinical studies of Myelodysplastic Syndromes (MDS) have been elusive
due to limited ability of MDS stem cells to engraft current immunodeficient murine hosts. …
due to limited ability of MDS stem cells to engraft current immunodeficient murine hosts. …
Whole-exome sequencing in evaluation of patients with venous thromboembolism
…, C Cromwell, N Bar, S Halene, N Neparidze… - Blood …, 2017 - ashpublications.org
Genetics play a significant role in venous thromboembolism (VTE), yet current clinical
laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin …
laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin …